
Onyema Ogbuagu
@dronyemaogbuagu
Inf diseases MD, FACP, FIDSA,
Assoc Prof Medicine & Pharmacology @ Yale. HHS ARV panel.
I love conducting trials for treatment/prevention of stubborn viruses!
ID: 1271098579260715014
11-06-2020 15:14:59
922 Tweet
13,13K Followers
68 Following




Dr. Onyema Ogbuagu from Yale School of Medicine discussed results from Phase 2 study evaluating LEN, TAB, and ZAB, every 6 months for HIV-1 treatment. The study found 96% virologic suppression at Week 26, similar to daily oral ART. #CROI2025 Gilead Sciences contagionlive.com/view/phase-2-s…







